- Home
- ALZN vs BTTC Comparison
ALZN vs BTTC Comparison
Compare ALZN & BTTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALZN | BTTC |
|---|---|---|
| Founded | 2016 | 1990 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 7.4M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | ALZN | BTTC |
|---|---|---|
| Price | $1.83 | $0.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $28.00 | N/A |
| AVG Volume (30 Days) | 107.2K | ★ 14.4M |
| Earning Date | 03-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 76.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.22 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.84 | $0.34 |
| 52 Week High | $2.68 | $11.22 |
Technical Indicators
Market Signals| Indicator | ALZN | BTTC |
|---|---|---|
| Relative Strength Index (RSI) | 62.16 | 48.72 |
| Support Level | $1.69 | $0.34 |
| Resistance Level | $2.22 | $0.85 |
| Average True Range (ATR) | 0.08 | 0.08 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 70.45 | 23.26 |
Price Performance
Historical ComparisonAbout ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.
About BTTC Black Titan Corporation Ordinary Shares
Black Titan Corp provides human resource and payroll consulting, software implementation, and training solutions using PeopleSoft platforms. The company's revenue is mainly derived from the provision of HCM solutions, followed by the provision of IT staff augmentation, outsourcing and consulting services.